InvestorsHub Logo
Followers 3
Posts 148
Boards Moderated 0
Alias Born 08/21/2020

Re: None

Thursday, 09/10/2020 12:17:43 PM

Thursday, September 10, 2020 12:17:43 PM

Post# of 1095

FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE.CN) (FRA:0K9A) CEO Raza Bokhari tells Proactive the group has submitted an Investigational New Drug (IND) application to the FDA for the use of its lead candidate FSD-201, or anti-inflammatory ultra-micronized-palmitoylethanolamide (PEA), to treat coronavirus patients. Bokhari says hopefully before the end of 2020, the group will initiate a Phase 2 trial to treat hospitalized coronavirus patients.